Real-World Evidence Uptake Is “Silver Lining” Of COVID-19 Response, USFDA’s Abernethy Says
• By Kate Rawson
Sponsors, regulators and patients have criteria that must be met for RWE technology to advance after the pandemic, Abernethy said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
